Science Round-up: Boeing rocket for NASA over budget could further delay launch and more
Boeing rocket for NASA over budget could further delay launch: audit
Boeing Co is building the largest rocket in NASA's history but the aerospace giant's "poor performance" has resulted in an $8.9 billion price tag that is double the initial budget and could further delay the launch, the U.S. space agency's watchdog office said on Wednesday. The first test launch of the Space Launch System rocket, which is supposed to send humans to the moon and ultimately allow deep space exploration, was most recently slated for mid-2020 with a crew launch to follow in 2022. The launches have been delayed at least three times.
J&J's Stelara succeeds in chronic bowel disease study
Johnson & Johnson said on Tuesday its blockbuster drug Stelara was found to be effective in treating a chronic bowel disease in a late-stage trial. Two doses of Stelara, already approved for psoriasis, psoriatic arthritis and Crohn's disease, was tested in 961 patients with moderate-to-severe ulcerative colitis (UC) who had failed prior therapy.
(With inputs from agencies.)
ALSO READ
End the Biden impeachment bid, White House urges Johnson in letter
End the Biden impeachment bid, White House urges Johnson in letter
US House Democrats offer to protect Republican Johnson for Ukraine aid
Former James Bond star George Lazenby approves of Aaron Taylor-Johnson as next Agent 007
Republican US Rep. Greene calls for vote to oust House Speaker Johnson, Punchbowl reports